Sectors
RNAC
Cartesian Therapeutics, Inc.
8.08
2 x 8.04
1 x 8.11
bid
ask
-
0.05
0.62%
01:03 PM
timesize
| Ytd | 12.07% | |
| 1y | -33.66% |
7.98
day range
8.31
5.60
52 week range
14.56
| Open | 8.07 | Prev Close | 8.13 | Low | 7.98 | High | 8.31 | Mkt Cap | 238.87M |
| Vol | 47.94K | Avg Vol | 280.31K | EPS | -3.72 | P/E | -2.19 | Forward P/E | -5.54 |
| Beta | 0.59 | Short Ratio | 15.83 | Inst. Own | 27.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 8.31 | 200-d Avg | 7.65 | 1yr Est | 38.17 |
| Income Statement | |||
| Total Revenue | 78.00K | ||
| Revenues (USD) | 78.00K | ||
| Gross Profit | 78.00K | ||
| Operating Expenses | 26.58M | ||
| Research and Development Expense | 19.46M | ||
| Selling, General and Administrative Expense | 7.11M | ||
| Operating Income | -26.50M | ||
| Net Income | -39.18M | ||
| Net Income Common Stock | -39.18M | ||
| Net Income Common Stock (USD) | -39.18M | ||
| Consolidated Income | -39.18M | ||
| Earnings per Basic Share | -1.46 | ||
| Earnings per Basic Share (USD) | -1.46 | ||
| Earnings per Diluted Share | -1.46 | ||
| Earning Before Interest & Taxes (EBIT) | -39.18M | ||
| Earning Before Interest & Taxes (USD) | -39.18M | ||
| Weighted Average Shares | 26.86M | ||
| Weighted Average Shares Diluted | 26.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 118.64M | ||
| Cash and Equivalents (USD) | 118.64M | ||
| Investments | 1.74M | ||
| Investments Non-Current | 1.74M | ||
| Trade and Non-Trade Receivables | 261.00K | ||
| Current Assets | 122.04M | ||
| Property, Plant & Equipment Net | 17.00M | ||
| Total Assets | 288.39M | ||
| Debt Current | 4.19M | ||
| Total Debt | 11.86M | ||
| Current Liabilities | 15.95M | ||
| Debt Non-Current | 7.67M | ||
| Total Liabilities | 436.51M | ||
| Accumulated Retained Earnings (Deficit) | -861.55M | ||
| Accumulated Other Comprehensive Income | -4.58M | ||
| Shareholders Equity | -148.12M | ||
| Shareholders Equity (USD) | -148.12M | ||
| Assets Non-Current | 166.35M | ||
| Total Debt (USD) | 11.86M | ||
| Goodwill and Intangible Assets | 48.16M | ||
| Liabilities Non-Current | 420.56M | ||
| Trade and Non-Trade Payables | 1.60M | ||
| Tax Liabilities | 6.95M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 850.00K | ||
| Net Cash Flow from Financing | 15.67M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.50M | ||
| Capital Expenditure | -27.00K | ||
| Issuance (Purchase) of Equity Shares | 15.67M | ||
| Net Cash Flow from Investing | -27.00K | ||
| Net Cash Flow from Operations | -22.13M | ||
| Effect of Exchange Rate Changes on Cash | -7.00K | ||
| Share Based Compensation | 2.42M | ||